A phase 1 study comparing the proposed biosimilar BS‐503a with bevacizumab in healthy male volunteers

Lignende værker

• A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
  af: Knight, Beverly, et al.
  Udgivet: (2016)
• A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers
  af: Shin, Donghoon, et al.
  Udgivet: (2020)
• A Phase I, Randomized, Single-Dose Study Evaluating the Biosimilarity of TAB008 to Bevacizumab in Healthy Volunteers
  af: Wang, Jin, et al.
  Udgivet: (2019)
• A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
  af: Liu, Ya-nan, et al.
  Udgivet: (2020)
• A phase I, randomized, double-blind, parallel, single-dose pharmacokinetic study to evaluate the biosimilarity of KM118 (proposed pertuzumab biosimilar) with reference pertuzumab (Perjeta®) in healthy male subjects
  af: Yan Li, et al.
  Udgivet: (2025-12-01)